Clinical Trials Sponsored by Pieris Pharmaceuticals GmbH

Total 282 results

Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) (PREDICT)

Infertility

Germany
Forest Laboratories
Merz Pharmaceuticals GmbH

Completed

Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism

Autism

United States
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Compliance and Efficacy in the Use of PICOPREP® (CLEAR)

Bowel Cleanliness

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Quality of Life With TESTIM® (LIFE)

Hypogonadism

Germany
CENTOGENE GmbH Rostock
Alnylam Pharmaceuticals

Recruiting

TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects (TRAMmoniTTR)

Cardiomyopathies | Polyneuropathies | Transthyretin Amyloidosis | Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Germany, Austria, Switzerland
CENTOGENE GmbH Rostock
Alexion Pharmaceuticals

Completed

Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)

Hypophosphatasia

Germany
GWT-TUD GmbH
Novartis Pharmaceuticals

Completed

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis (Secu_in_AD)

Dermatitis, Atopic | Eczema, Atopic | Neurodermatitis, Atopic

Germany
Forest Laboratories
Merz Pharmaceuticals GmbH

Completed

Open-label Study of Safety and Tolerability of Memantine in Children With Autism

Autism | Pediatric Autism

United States
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

User Surveillance in Ulcerative Colitis (CARE)

Ulcerative Colitis

Germany
Pierre Fabre Pharma GmbH
DocCheck Medical Services GmbH

Completed

JAVLOR® Online Non-Interventional Trial (JONAS-1)

Transitional Cell Carcinoma

Germany
Sideris Pharmaceuticals

Terminated

Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia

Iron Overload | Beta-Thalassemia

United States, Canada, Lebanon, Thailand, Turkey
Tigris Pharmaceuticals

Completed

A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) (TG-003)

Cervical Intraepithelial Neoplasia | Uterine Cervical Dysplasia

United States
Tigris Pharmaceuticals

Terminated

Study of AFP464 +/- Faslodex in ER + Breast Cancer

Breast Neoplasm

United States
Tigris Pharmaceuticals

Completed

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Cervical Intraepithelial Neoplasia | Uterine Cervical Dysplasia

United States
Tigris Pharmaceuticals

Withdrawn

Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer

Breast Neoplasm
Aderis Pharmaceuticals

Completed

Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation

Atrial Fibrillation

United States
Janssen Pharmaceutical K.K.
Grünenthal GmbH

Completed

Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants

Pain | Cancer

Japan
SocraTec R&D GmbH
SocraMetrics GmbH; Glatt Pharmaceutical Services GmbH & Co. KG

Completed

Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration

Comparative Bioavailability

Germany
Pierre Fabre Medicament
Pierre Fabre Pharma GmbH

Completed

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

NSCLC

Germany
Xeris Pharmaceuticals

Completed

Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D

Diabetes Mellitus, Type 1 | Insulin-dependent Diabetes Mellitus

United States
Xeris Pharmaceuticals

Completed

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Hypoglycemia | Diabetes Mellitus, Type 1

United States, Canada
Merz Therapeutics GmbH
Heinrich-Heine University, Duesseldorf

Recruiting

Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia (RELY-CD)

Cervical Dystonia

Germany
Merz Aesthetics GmbH
Merz Pharmaceuticals GmbH

Completed

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Moderate to Severe Glabellar Frown Lines

United States, Germany
Merz Aesthetics GmbH
Merz Pharmaceuticals GmbH

Completed

Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles

Décolleté Wrinkles

Germany
Xeris Pharmaceuticals

Active, not recruiting

Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism

Hypothyroidism

United States
Xeris Pharmaceuticals

Completed

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

Hypoglycemia

Canada
Xeris Pharmaceuticals

Completed

Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery

Hyperinsulinemic Hypoglycemia

United States
Xeris Pharmaceuticals

Completed

G-Pen™ for Hypoglycemia Rescue in T1D Patients

Hypoglycemia

United States
EpiEndo Pharmaceuticals
FGK Clinical Research GmbH

Completed

Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD

Chronic Obstructive Pulmonary Disease | COPD

Germany, United Kingdom
EpiEndo Pharmaceuticals
FGK Clinical Research GmbH

Completed

Clinical Trial Comparing the Pharmacological Effects of EP395 With Placebo in Healthy Adults

Chronic Obstructive Pulmonary Disease | COPD

Germany
Ganymed Pharmaceuticals GmbH

Completed

Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer

Solid Tumors

Germany, Latvia
Mylan Pharmaceuticals Inc
Mylan GmbH

Completed

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

Healthy
Ganymed Pharmaceuticals GmbH

Completed

Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR) (OVAR)

Ovarian Cancer

Belgium, Germany
University Hospital, Toulouse
Merz Pharmaceuticals GmbH

Completed

Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment (BacloTox)

Muscle Spasticity

France
BioNTech RNA Pharmaceuticals GmbH

Completed

RBL001/RBL002 Phase I Clinical Trial (MERIT)

Melanoma

Austria, Germany
BioNTech RNA Pharmaceuticals GmbH

Completed

IVAC MUTANOME Phase I Clinical Trial

Melanoma

Austria, Germany
Ganymed Pharmaceuticals GmbH

Completed

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

Solid Tumors

Germany, Switzerland, Latvia, Bulgaria, Lithuania
Innovaderm Research Inc.
Merz Pharmaceuticals GmbH

Completed

Treatment of Notalgia Paresthetica With Xeomin

Notalgia Paresthetica

Canada
Pherin Pharmaceuticals, Inc.

Completed

Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
Pherin Pharmaceuticals, Inc.

Unknown

Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder (PH80-PMD)

Premenstrual Dysphoric Disorder

United States
Pherin Pharmaceuticals, Inc.

Completed

Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia (PH94B-SAD)

Social Anxiety Disorder | Social Phobia

United States
Lee's Pharmaceutical Limited
APOGEPHA Arzneimittel GmbH

Completed

Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder

Overactive Bladder

China
Pierre Fabre Pharma GmbH
iOMEDICO AG

Completed

Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer | Non Small Cell Lung Carcinoma

Germany
Merz Pharmaceuticals GmbH
Merz North America, Inc.

Completed

Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex

Cervical Dystonia

United States
Merz Pharmaceuticals GmbH
LLC Merz Pharma, Russia

Completed

A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss

Female Pattern Hair Loss | Androgenetic Alopecia (AGA) | Ludwig Type 1 | Ludwig Type 2

Russian Federation
Affectis Pharmaceuticals AG
FGK Clinical Research GmbH

Completed

Cimicoxib for the Treatment of Major Depression (SECIM)

Major Depression

Austria, Czech Republic, Germany
University Hospital, Bonn
Actelion Pharmaceuticals Deutschland GmbH

Unknown

Persistent Pulmonary Artery Hypertension After Valve Replacement (SALT)

Persistent Severe PH After Valve Therapy

Germany
Conatus Pharmaceuticals Inc.
FGK Clinical Research GmbH

Completed

Study of CTS-1027 in Hepatitis C Patients

Chronic Hepatitis C Virus Infection

United States
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Recruiting

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Prostate Cancer

Japan
Merz North America, Inc.
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines (ULTRA I)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

United States

Clinical Trials Sponsored by Pieris Pharmaceuticals GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations